These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10219780)

  • 1. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy.
    Griffiths PD; Dobson BR; Jones GR; Clarke DT
    Brain; 1999 Apr; 122 ( Pt 4)():667-73. PubMed ID: 10219780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease.
    Griffiths PD; Crossman AR
    Dementia; 1993; 4(2):61-5. PubMed ID: 8358514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
    Hardman CD; Halliday GM
    Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of neuronal iron deposits in Parkinson's disease brain tissue by synchrotron x-ray spectromicroscopy.
    Brooks J; Everett J; Lermyte F; Tjendana Tjhin V; Sadler PJ; Telling N; Collingwood JF
    J Trace Elem Med Biol; 2020 Dec; 62():126555. PubMed ID: 32526631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histochemical distribution of non-haem iron in the human brain.
    Morris CM; Candy JM; Oakley AE; Bloxham CA; Edwardson JA
    Acta Anat (Basel); 1992; 144(3):235-57. PubMed ID: 1529678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
    Nisbet AP; Eve DJ; Kingsbury AE; Daniel SE; Marsden CD; Lees AJ; Foster OJ
    Neuroscience; 1996 Nov; 75(2):389-406. PubMed ID: 8931005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease.
    Bunzeck N; Singh-Curry V; Eckart C; Weiskopf N; Perry RJ; Bain PG; Düzel E; Husain M
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1136-42. PubMed ID: 24025315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
    Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH
    Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
    Dexter DT; Wells FR; Lees AJ; Agid F; Agid Y; Jenner P; Marsden CD
    J Neurochem; 1989 Jun; 52(6):1830-6. PubMed ID: 2723638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchrotron XRF imaging of Alzheimer's disease basal ganglia reveals linear dependence of high-field magnetic resonance microscopy on tissue iron concentration.
    Finnegan ME; Visanji NP; Romero-Canelon I; House E; Rajan S; Mosselmans JFW; Hazrati LN; Dobson J; Collingwood JF
    J Neurosci Methods; 2019 May; 319():28-39. PubMed ID: 30851339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased ferritin levels in brain in Parkinson's disease.
    Dexter DT; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees AJ; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1990 Jul; 55(1):16-20. PubMed ID: 2355217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.
    Bartzokis G; Cummings JL; Markham CH; Marmarelis PZ; Treciokas LJ; Tishler TA; Marder SR; Mintz J
    Magn Reson Imaging; 1999 Feb; 17(2):213-22. PubMed ID: 10215476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.
    Sofic E; Riederer P; Heinsen H; Beckmann H; Reynolds GP; Hebenstreit G; Youdim MB
    J Neural Transm; 1988; 74(3):199-205. PubMed ID: 3210014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XANES spectroscopy of a single neuron from a patient with Parkinson's disease.
    Yoshida S; Ektessabi A; Fujisawa S
    J Synchrotron Radiat; 2001 Mar; 8(Pt 2):998-1000. PubMed ID: 11513007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron and ferritin in substantia nigra in Parkinson's disease.
    Jellinger KA; Kienzl E; Rumpelmaier G; Paulus W; Riederer P; Stachelberger H; Youdim MB; Ben-Shachar D
    Adv Neurol; 1993; 60():267-72. PubMed ID: 8420142
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.